see the EMC SmPC and NHS Wegovy page [13] Tirzepatide (Mounjaro) approved by the MHRA with NICE guidance in place (NICE TA924)
More people achieved at least a 5% weight reduction, but the drug caused higher rates of mild-to-moderate gastrointestinal issues
However, in what ways might they differ from the brand-name version, and potentially benefit you
If you have labs from within the past six months, including CBC, CMP, TSH, and A1C, you can upload them to our secure HIPAA portal during your patient intake after enrollment
There are other ways that GLP-1 medications can impact blood pressure: Reduced sodium intake: People taking GLP-1s may end up eating less salty foods because they eat less overall
The drug must be treating that condition, not simply supporting general wellness